Solara Active Pharma Sciences Ltd
Solara Active Pharma Allots 8,300 ESOP Shares, Paid-Up Capital Increases
FUNDRAISE
● No Immediate Change
LOW RISK
📅 Filed on BSE: 16 Oct 2026, 01:43 PM IST · BSE ID: 034b92e2-ef72-475b-bc3d-17f08c56dcda
View Original BSE Filing (PDF)
💡
In Simple Terms
Solara Active Pharma issued new shares to employees who exercised their stock options, slightly increasing its total capital.
🤖 AI Summary
- Solara Active Pharma Sciences allotted 8,300 equity shares under its ESOP plan.
- Allotment approved by the Board of Directors on October 16, 2026.
- Total paid-up capital increases to Rs. 48,16,99,569.00.
- Fully paid-up equity shares increase to 4,80,90,117 post-allotment.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares Allotted
8,300
Face Value per Equity Share
Rs. 10/-
Paid up capital before ESOP allotment
48,16,16,569.00
Paid up capital post ESOP allotment
48,16,99,569.00
Number of Fully Paid Equity Shares (post allotment)
4,80,90,117
🏢 How This Affects the Company
The company's total paid-up capital has increased by the aggregate face value of the allotted shares, impacting its equity structure.
The issuance of shares under the ESOP plan impacts the company's shareholding structure by increasing the number of outstanding equity shares.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
Existing shareholders are affected by a marginal dilution of their percentage ownership due to the issuance of new equity shares.
🔍
Management Signal
Management continues to utilize the ESOP Plan 2018 to reward and retain employees.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarterly results announcement for shareholding patterns.
Future ESOP exercise disclosures by the company.
Company's annual report for detailed ESOP reconciliation.
LOW RISK
Routine ESOP allotment with minimal impact on total share count and capital.
💡 Investor Takeaway
Solara Active Pharma Sciences allotted 8,300 equity shares under ESOP, increasing total paid-up capital to Rs. 48,16,99,569.00. Fully paid equity shares now stand at 4,80,90,117.
⚖️ Strengths & Concerns
✅ Positives
- Company continues to incentivize employees through its existing ESOP Plan 2018.
- Increased equity base post-allotment of 8,300 shares under employee stock options.
📅 Company Track Record
Previously, Solara Active Pharma Sciences had allotted 2,200 ESOP shares in May 2026, increasing its paid-up capital.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
How many equity shares did Solara Active Pharma Sciences allot under its ESOP plan?
Solara Active Pharma Sciences allotted 8,300 equity shares pursuant to the exercise of options under the Solara Employee Stock Option Plan 2018.
What is the total paid-up capital of Solara Active Pharma Sciences after the recent allotment?
Following the allotment, the total paid-up capital of Solara Active Pharma Sciences has increased to Rs. 48,16,99,569.00.
What is the face value of the equity shares allotted by Solara Active Pharma Sciences?
The equity shares allotted by Solara Active Pharma Sciences have a face value of Rs. 10/- each.
How many fully paid equity shares does Solara Active Pharma Sciences have after this allotment?
After the allotment, Solara Active Pharma Sciences has 4,80,90,117 fully paid equity shares.
Questions based on this BSE filing only. For information purposes.